Home › Companies › Arcturus Therapeutics Holdings Inc. › 2025-2026

Arcturus Therapeutics Holdings Inc. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Arcturus Therapeutics Holdings Inc.’s Form 8-K, filed 2026-06-05 (Item 5.07 on EDGAR). Page generated 02 October 2026.

  • 10Reported items
  • 144Asset managers
  • 1,671Fund votes
  • 2026-06-05Meeting date

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Arcturus Therapeutics Holdings Inc. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Arcturus Therapeutics Holdings Inc.

These tallies are Arcturus Therapeutics Holdings Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed 2026-06-05 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Arcturus Therapeutics Holdings Inc. — official shareholder meeting results, meeting held 2026-06-05
Ballot itemForAgainst AbstainWithheldBroker non-votesOutcome
The proposal was approved. Proposal No. 3 21,378,01746,82310,349 ---- Majority: yes

Source: Arcturus Therapeutics Holdings Inc., Form 8-K, filed with the SEC on 2026-06-05 — read the filing on EDGAR.

How asset managers voted at the Arcturus Therapeutics Holdings Inc. 2025-2026 meeting

Each item below shows how the 144 asset managers that disclosed a Arcturus Therapeutics Holdings Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of Arcturus Therapeutics Holdings Inc.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.

1. Approval, by non-binding advisory vote, of the resolution approving the Company's Named Executive Officer compensation, as provided in Proposal Number 2 of the Proxy Statement.

SECTION 14A SAY-ON-PAY VOTES

Combines 3 wordings of this item as funds reported it.

98% fund support · no official result

FOR 98%

The 142 asset managers below cast 98% of the shares they voted on this item FOR (14,726,322 for, 260,594 against).

FOR: 14,726,322 (98.3%)AGAINST: 260,594 (1.7%)
Largest asset managers voting on “Approval, by non-binding advisory vote, of the resolution approving the Company's Named Executive Officer comp” at Arcturus Therapeutics Holdings Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
Federated Hermes4,418,2960 00For
ARK ETF Trust2,666,4110 00For
Amova Asset Management Co., Ltd.2,282,6950 00For
Vanguard1,604,2411 00For
BlackRock991,09137 00For
Charles Schwab457,2540 00For
Empire Life Investments Inc.383,4930 00For
State Street183,4691,719 00For
HEARTLAND ADVISORS INC0171,800 00Against
Two Sigma159,0660 00For
Fidelity140,4413,735 00For
ARK Investment Management LLC137,2220 00For
JACOBS LEVY EQUITY MANAGEMENT, INC130,7180 00For
GEODE CAPITAL MANAGEMENT, LLC123,9040 00For
Northern Trust109,772815 00For
Goldman Sachs87,4960 00For
MASSACHUSETTS FINANCIAL SERVICES CO /MA/69,6940 00For
MFS49,5840 00For
Russell Investments43,8320 00For
American Century042,684 00Against
SEI38,9370 00For
ACADIAN ASSET MANAGEMENT LLC37,4150 00For
MELLON INVESTMENTS Corp35,9860 00For
Allspring35,1460 00For
DE Shaw34,2290 00For

Showing the 25 largest of 142 asset managers. See all 142 in the interactive database.

2. Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Edward W. Holmes

DIRECTOR ELECTIONS

Combines 6 wordings of this item as funds reported it.

100% fund support · no official result

FOR 99.0%

The 51 asset managers below cast 100% of the shares they voted on this item FOR (7,470,985 for, 0 against).

FOR: 7,470,985 (99.0%)ABSTAIN: 73,205 (1.0%)
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at Arcturus Therapeutics Holdings Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
ARK ETF Trust2,666,4110 00For
Federated Hermes2,209,1480 00For
Vanguard1,550,8930 1,1600For
BlackRock386,8890 00For
Charles Schwab228,6270 00For
Fidelity140,4410 00For
MFS49,5840 00For
SEI Exchange Traded Funds00 32,7370Abstain
Equitable29,2570 00For
CLEARWATER INVESTMENT TRUST23,1460 00For
American Century21,1860 00For
Lincoln Financial20,0710 00For
Allspring17,5730 00For
Global X00 16,2420Abstain
Nationwide15,7510 00For
Jacob Funds Inc.13,3700 00For
QUANTITATIVE MASTER SERIES LLC13,2000 00For
Russell Investments00 12,2130Abstain
Goldman Sachs11,6560 00For
Pacific Life9,8140 00For
Bridge Builder Trust9,2510 00For
MASTER INVESTMENT PORTFOLIO8,9130 00For
Blackstone Alternative Investment Funds6,2000 00For
Invesco5,5750 00For
ProShares4,8190 00For

Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.

3. Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Jing L. Marantz

DIRECTOR ELECTIONS

Combines 6 wordings of this item as funds reported it.

100% fund support · no official result

FOR 99.9%

The 51 asset managers below cast 100% of the shares they voted on this item FOR (7,539,348 for, 0 against).

FOR: 7,539,348 (99.9%)ABSTAIN: 4,841 (0.1%)
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at Arcturus Therapeutics Holdings Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
ARK ETF Trust2,666,4110 00For
Federated Hermes2,209,1480 00For
Vanguard1,549,6630 2,3890For
BlackRock386,8890 00For
Charles Schwab228,6270 00For
Fidelity140,4410 00For
MFS49,5840 00For
SEI Exchange Traded Funds32,7370 00For
Equitable29,2570 00For
CLEARWATER INVESTMENT TRUST23,1460 00For
American Century21,1860 00For
Lincoln Financial20,0710 00For
Allspring17,5730 00For
Global X16,2420 00For
Nationwide15,7510 00For
Jacob Funds Inc.13,3700 00For
QUANTITATIVE MASTER SERIES LLC13,2000 00For
Russell Investments12,2130 00For
Goldman Sachs11,6560 00For
Pacific Life9,8140 00For
Bridge Builder Trust9,2510 00For
MASTER INVESTMENT PORTFOLIO8,9130 00For
Blackstone Alternative Investment Funds6,2000 00For
Invesco5,5750 00For
ProShares4,8190 00For

Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.

4. Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. John Markels

DIRECTOR ELECTIONS

Combines 6 wordings of this item as funds reported it.

100% fund support · no official result

FOR 99.9%

The 51 asset managers below cast 100% of the shares they voted on this item FOR (7,539,348 for, 0 against).

FOR: 7,539,348 (99.9%)ABSTAIN: 4,841 (0.1%)
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at Arcturus Therapeutics Holdings Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
ARK ETF Trust2,666,4110 00For
Federated Hermes2,209,1480 00For
Vanguard1,549,6630 2,3890For
BlackRock386,8890 00For
Charles Schwab228,6270 00For
Fidelity140,4410 00For
MFS49,5840 00For
SEI Exchange Traded Funds32,7370 00For
Equitable29,2570 00For
CLEARWATER INVESTMENT TRUST23,1460 00For
American Century21,1860 00For
Lincoln Financial20,0710 00For
Allspring17,5730 00For
Global X16,2420 00For
Nationwide15,7510 00For
Jacob Funds Inc.13,3700 00For
QUANTITATIVE MASTER SERIES LLC13,2000 00For
Russell Investments12,2130 00For
Goldman Sachs11,6560 00For
Pacific Life9,8140 00For
Bridge Builder Trust9,2510 00For
MASTER INVESTMENT PORTFOLIO8,9130 00For
Blackstone Alternative Investment Funds6,2000 00For
Invesco5,5750 00For
ProShares4,8190 00For

Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.

5. Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Magda Marquet

DIRECTOR ELECTIONS

Combines 6 wordings of this item as funds reported it.

100% fund support · no official result

FOR 99.9%

The 51 asset managers below cast 100% of the shares they voted on this item FOR (7,541,665 for, 0 against).

FOR: 7,541,665 (100.0%)ABSTAIN: 2,524 (0.0%)
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at Arcturus Therapeutics Holdings Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
ARK ETF Trust2,666,4110 00For
Federated Hermes2,209,1480 00For
Vanguard1,549,6630 2,3890For
BlackRock386,8890 00For
Charles Schwab228,6270 00For
Fidelity140,4410 00For
MFS49,5840 00For
SEI Exchange Traded Funds32,7370 00For
Equitable29,2570 00For
CLEARWATER INVESTMENT TRUST23,1460 00For
American Century21,1860 00For
Lincoln Financial20,0710 00For
Allspring17,5730 00For
Global X16,2420 00For
Nationwide15,7510 00For
Jacob Funds Inc.13,3700 00For
QUANTITATIVE MASTER SERIES LLC13,2000 00For
Russell Investments12,2130 00For
Goldman Sachs11,6560 00For
Pacific Life9,8140 00For
Bridge Builder Trust9,2510 00For
MASTER INVESTMENT PORTFOLIO8,9130 00For
Blackstone Alternative Investment Funds6,2000 00For
Invesco5,5750 00For
ProShares4,8190 00For

Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.

6. Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Moncef Slaoui

DIRECTOR ELECTIONS

Combines 6 wordings of this item as funds reported it.

100% fund support · no official result

FOR 99.9%

The 51 asset managers below cast 100% of the shares they voted on this item FOR (7,540,714 for, 0 against).

FOR: 7,540,714 (100.0%)ABSTAIN: 3,476 (0.0%)
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at Arcturus Therapeutics Holdings Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
ARK ETF Trust2,666,4110 00For
Federated Hermes2,209,1480 00For
Vanguard1,550,8940 1,1590For
BlackRock386,8890 00For
Charles Schwab228,6270 00For
Fidelity140,4410 00For
MFS49,5840 00For
SEI Exchange Traded Funds32,7370 00For
Equitable29,2570 00For
CLEARWATER INVESTMENT TRUST23,1460 00For
American Century21,1860 00For
Lincoln Financial20,0710 00For
Allspring17,5730 00For
Global X16,2420 00For
Nationwide15,7510 00For
Jacob Funds Inc.13,3700 00For
QUANTITATIVE MASTER SERIES LLC13,2000 00For
Russell Investments12,2130 00For
Goldman Sachs11,6560 00For
Pacific Life9,8140 00For
Bridge Builder Trust9,2510 00For
MASTER INVESTMENT PORTFOLIO8,9130 00For
Blackstone Alternative Investment Funds6,2000 00For
Invesco5,5750 00For
ProShares4,8190 00For

Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.

7. Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Dr. Peter Farrell

DIRECTOR ELECTIONS

Combines 6 wordings of this item as funds reported it.

100% fund support · no official result

FOR 99.9%

The 51 asset managers below cast 100% of the shares they voted on this item FOR (7,541,665 for, 0 against).

FOR: 7,541,665 (100.0%)ABSTAIN: 2,524 (0.0%)
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at Arcturus Therapeutics Holdings Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
ARK ETF Trust2,666,4110 00For
Federated Hermes2,209,1480 00For
Vanguard1,549,6630 2,3890For
BlackRock386,8890 00For
Charles Schwab228,6270 00For
Fidelity140,4410 00For
MFS49,5840 00For
SEI Exchange Traded Funds32,7370 00For
Equitable29,2570 00For
CLEARWATER INVESTMENT TRUST23,1460 00For
American Century21,1860 00For
Lincoln Financial20,0710 00For
Allspring17,5730 00For
Global X16,2420 00For
Nationwide15,7510 00For
Jacob Funds Inc.13,3700 00For
QUANTITATIVE MASTER SERIES LLC13,2000 00For
Russell Investments12,2130 00For
Goldman Sachs11,6560 00For
Pacific Life9,8140 00For
Bridge Builder Trust9,2510 00For
MASTER INVESTMENT PORTFOLIO8,9130 00For
Blackstone Alternative Investment Funds6,2000 00For
Invesco5,5750 00For
ProShares4,8190 00For

Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.

8. Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: James Barlow

DIRECTOR ELECTIONS

Combines 6 wordings of this item as funds reported it.

100% fund support · no official result

FOR 99.9%

The 51 asset managers below cast 100% of the shares they voted on this item FOR (7,540,506 for, 0 against).

FOR: 7,540,506 (100.0%)ABSTAIN: 3,683 (0.0%)
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at Arcturus Therapeutics Holdings Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
ARK ETF Trust2,666,4110 00For
Federated Hermes2,209,1480 00For
Vanguard1,548,5040 3,5480For
BlackRock386,8890 00For
Charles Schwab228,6270 00For
Fidelity140,4410 00For
MFS49,5840 00For
SEI Exchange Traded Funds32,7370 00For
Equitable29,2570 00For
CLEARWATER INVESTMENT TRUST23,1460 00For
American Century21,1860 00For
Lincoln Financial20,0710 00For
Allspring17,5730 00For
Global X16,2420 00For
Nationwide15,7510 00For
Jacob Funds Inc.13,3700 00For
QUANTITATIVE MASTER SERIES LLC13,2000 00For
Russell Investments12,2130 00For
Goldman Sachs11,6560 00For
Pacific Life9,8140 00For
Bridge Builder Trust9,2510 00For
MASTER INVESTMENT PORTFOLIO8,9130 00For
Blackstone Alternative Investment Funds6,2000 00For
Invesco5,5750 00For
ProShares4,8190 00For

Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.

9. Approval of the election of the following individuals as directors of the Company, to serve until the next annual meeting of stockholders: Joseph E. Payne

DIRECTOR ELECTIONS

Combines 6 wordings of this item as funds reported it.

100% fund support · no official result

FOR 99.9%

The 51 asset managers below cast 100% of the shares they voted on this item FOR (7,541,665 for, 0 against).

FOR: 7,541,665 (100.0%)ABSTAIN: 2,524 (0.0%)
Largest asset managers voting on “Approval of the election of the following individuals as directors of the Company, to serve until the next ann” at Arcturus Therapeutics Holdings Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
ARK ETF Trust2,666,4110 00For
Federated Hermes2,209,1480 00For
Vanguard1,549,6630 2,3890For
BlackRock386,8890 00For
Charles Schwab228,6270 00For
Fidelity140,4410 00For
MFS49,5840 00For
SEI Exchange Traded Funds32,7370 00For
Equitable29,2570 00For
CLEARWATER INVESTMENT TRUST23,1460 00For
American Century21,1860 00For
Lincoln Financial20,0710 00For
Allspring17,5730 00For
Global X16,2420 00For
Nationwide15,7510 00For
Jacob Funds Inc.13,3700 00For
QUANTITATIVE MASTER SERIES LLC13,2000 00For
Russell Investments12,2130 00For
Goldman Sachs11,6560 00For
Pacific Life9,8140 00For
Bridge Builder Trust9,2510 00For
MASTER INVESTMENT PORTFOLIO8,9130 00For
Blackstone Alternative Investment Funds6,2000 00For
Invesco5,5750 00For
ProShares4,8190 00For

Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.

10. RATIFICATION OF THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2026.

AUDIT-RELATED

100% fund support · no official result

FOR 100%

The 51 asset managers below cast 100% of the shares they voted on this item FOR (7,537,388 for, 0 against).

FOR: 7,537,388 (100.0%)
Largest asset managers voting on “RATIFICATION OF THE APPOINTMENT OF DELOITTE & TOUCHE LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUN” at Arcturus Therapeutics Holdings Inc., 2025-2026
Asset managerForAgainst AbstainWithheldVote
ARK ETF Trust2,666,4110 00For
Federated Hermes2,209,1480 00For
Vanguard1,552,0530 00For
BlackRock386,8890 00For
Charles Schwab228,6270 00For
Fidelity140,4410 00For
MFS49,5840 00For
SEI Exchange Traded Funds32,7370 00For
Equitable29,2570 00For
American Century21,1860 00For
Lincoln Financial20,0710 00For
Allspring17,5730 00For
Investment Managers Series Trust II16,3440 00For
Global X16,2420 00For
Nationwide15,7510 00For
Jacob Funds Inc.13,3700 00For
QUANTITATIVE MASTER SERIES LLC13,2000 00For
Russell Investments12,2130 00For
Goldman Sachs11,6560 00For
Pacific Life9,8140 00For
Bridge Builder Trust9,2510 00For
MASTER INVESTMENT PORTFOLIO8,9130 00For
Blackstone Alternative Investment Funds6,2000 00For
Invesco5,5750 00For
ProShares4,8190 00For

Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.

Largest Arcturus Therapeutics Holdings Inc. shareholders voting in 2025-2026

Ranked by the number of Arcturus Therapeutics Holdings Inc. shares each manager voted on the most widely held ballot item of the 2025-2026 meeting, shown as a share of the 28,423,069 shares outstanding at the time of that meeting.

Top Arcturus Therapeutics Holdings Inc. shareholders by shares voted, 2025-2026
#Asset manager % of shares outstanding
1Federated Hermes 15.54%
2ARK ETF Trust 9.38%
3Amova Asset Management Co., Ltd. 8.03%
4Vanguard 5.64%
5BlackRock 3.49%
6Charles Schwab 1.61%
7Empire Life Investments Inc. 1.35%
8State Street 0.65%
9HEARTLAND ADVISORS INC 0.60%
10Two Sigma 0.56%

Reported Arcturus Therapeutics Holdings Inc. ownership

Positions disclosed to the SEC on Schedules 13D and 13G, Form 13F and the company’s own proxy statement (DEF 14A).

Arcturus Therapeutics Holdings Inc. beneficial owners on record for the 2025-2026 proxy season
Holder % outstanding Disclosure
Federated Hermes, Inc. 11.62% 13G
BlackRock 9.19% 13F
Vanguard Group 7.35% 13F
Two Sigma 3.81% 13F
Geode Capital 2.33% 13F
State Street 1.91% 13F
Millennium Management 1.68% 13F
Dimensional Fund Advisors 1.01% 13F
D.E. Shaw 0.89% 13F
Northern Trust 0.77% 13F

Percentages above are of 28,423,069 shares outstanding, as reported by Arcturus Therapeutics Holdings Inc. on its Form 10-Q dated 2026-05-05 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, so the percentages are the ones that were true then, not ones restated against today’s share count.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered investment companies and institutional managers disclose how they voted every proxy, and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Arcturus Therapeutics Holdings Inc.’s 10-Q dated 2026-05-05. This page is a static snapshot rebuilt weekly on 02 October 2026; a live search always shows the current data.

At Arcturus Therapeutics Holdings Inc.'s shareholder meeting held 2026-06-05, in the 2025-2026 proxy season, 144 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,671 separate fund positions. Their filings are grouped here into 10 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. Arcturus Therapeutics Holdings Inc.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — Approval, by non-binding advisory vote, of the resolution approving the Company's Named… — the reporting funds cast 98% of the shares they voted in favour (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). That is the aggregate of those managers' own N-PX disclosures, not the company's certified result, and the funds are a subset of all shareholders.

Arcturus Therapeutics Holdings Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).